Medicine Overview of Taflan SUD 0.0015% drops
Instill into conjunctival sac of affected eye(s)
Do not exceed once daily dosing regimen; more frequent administration of prostaglandin analogs may lessen the IOP lowering effect
Reduction of intraocular pressure starts approximately 2 – 4 hours after first administration with maximum effect reached after 12 hr
If other topical ophthalmics are prescribed, each should be administered 5 minutes apart
Elevated Intraocular Pressure
Indicated for reducing elevated IOP in patients with open-angle glaucoma or ocular hypertension
Instill 1 drop in affected eye(s) once daily in the evening
Causes changes to pigmented tissues; most frequently reported changes have been of the iris, eyelid, and eyelashes; pigmentation changes of the iris is likely permanent Increases length, color, thickness, and number of eyelashes
Caution with active intraocular inflammation (may exacerbate condition)
Macular edema reported; caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or with known risk factors for macular edema.
Lactation: Unknown whether distributed in breast milk.
>10%
Conjunctival hyperemia (4-20%)
1-10%
Ocular stinging (7%),Ocular pruritus/allergic conjunctivitis (5%),Cataract (3%),Growth of eyelashes (2%),Blurred vision (2%)
Reviews
Clear filtersThere are no reviews yet.